ArticleJournal of aging & social policy2024
Analysis of the First Round of Public Comments for the National Coverage Determination for Monoclonal Antibodies in the Treatment of Alzheimer's Disease.
Jenna Wahl et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.